{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:52:16Z","timestamp":1790776336185,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ebiom.2022.104232","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T13:41:38Z","timestamp":1660830098000},"page":"104232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"C","title":["Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-0535","authenticated-orcid":false,"given":"Kenrie P.Y.","family":"Hui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Chun","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.W.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hin-Wo","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel H.H.","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haogao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velda L.Y.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Yung","family":"Sit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.Y.","family":"Hsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timmy W.K.","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo L.M.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7902","key":"10.1016\/j.ebiom.2022.104232_bib0001","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104232_bib0002","series-title":"COVID-19 Weekly Epidemiological Update, 18 May 2022","year":"2022"},{"key":"10.1016\/j.ebiom.2022.104232_bib0003","unstructured":"CoVariants. Overview of variants\/mutations. https:\/\/covariants.org\/variants. Accessed 22 April 2022."},{"issue":"10","key":"10.1016\/j.ebiom.2022.104232_bib0004","article-title":"Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022","volume":"27","author":"Fonager","year":"2022","journal-title":"Euro Surveillance"},{"issue":"7906","key":"10.1016\/j.ebiom.2022.104232_bib0005","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","article-title":"Antibody evasion properties of SARS-CoV-2 Omicron sublineages","volume":"604","author":"Iketani","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104232_bib0006","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S1473-3099(22)00224-9","article-title":"Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3","volume":"22","author":"Arora","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"16","key":"10.1016\/j.ebiom.2022.104232_bib0007","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMc2201849","article-title":"Neutralization of the SARS-CoV-2 omicron BA.1 and BA.2 variants","volume":"386","author":"Yu","year":"2022","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ebiom.2022.104232_bib0008","article-title":"SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022","volume":"27","author":"Cheng","year":"2022","journal-title":"Euro Surveillance"},{"issue":"13","key":"10.1016\/j.ebiom.2022.104232_bib0009","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"Proc Nat Acad Sci USA"},{"issue":"7902","key":"10.1016\/j.ebiom.2022.104232_bib0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104232_bib0011","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.3201\/eid2611.203254","article-title":"In-flight transmission of SARS-CoV-2","volume":"26","author":"Choi","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"7831","key":"10.1016\/j.ebiom.2022.104232_bib0012","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41586-020-2334-5","article-title":"Infection of dogs with SARS-CoV-2","volume":"586","author":"Sit","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104232_bib0014","article-title":"Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households","author":"Lyngse","year":"2022","journal-title":"medRxiv (Preprint)"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104232_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32121-6","article-title":"Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England","volume":"13","author":"Elliott","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104232_bib0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.chom.2022.01.006","article-title":"Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission","volume":"30","author":"Escalera","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"7902","key":"10.1016\/j.ebiom.2022.104232_bib0016","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","article-title":"Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant","volume":"603","author":"Suzuki","year":"2022","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104232_bib0017","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41564-021-00954-4","article-title":"SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution","volume":"6","author":"Zahradn\u00edk","year":"2021","journal-title":"Nature Microbiol"},{"issue":"7917","key":"10.1016\/j.ebiom.2022.104232_bib0018","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-022-04856-1","article-title":"Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2","volume":"607","author":"Uraki","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104232_bib0019","article-title":"SARS-CoV-2 Omicron spike mediated immune escape and tropism shift","author":"Gupta","year":"2022","journal-title":"Res Sq., (rs.3.rs)"},{"issue":"7917","key":"10.1016\/j.ebiom.2022.104232_bib0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-022-04856-1","article-title":"Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2","volume":"607","author":"Uraki","year":"2022","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104232_bib0021","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.cell.2022.04.035","article-title":"Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike","volume":"185","author":"Yamasoba","year":"2022","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104232_bib0022","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ajpath.2022.01.007","article-title":"Signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with coronavirus disease 2019 caused by the omicron variant of severe acute respiratory syndrome coronavirus 2 in Houston, Texas","volume":"192","author":"Christensen","year":"2022","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104232_bib0023","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.chom.2021.11.005","article-title":"Nucleocapsid mutations R203K\/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2","volume":"29","author":"Wu","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"7807","key":"10.1016\/j.ebiom.2022.104232_bib0024","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"7816","key":"10.1016\/j.ebiom.2022.104232_bib0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104232_bib0026","series-title":"Weekly Epidemiological Update on COVID-19 - 6 July 2022","year":"2022"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104232_bib0027","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S1473-3099(22)00422-4","article-title":"Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5","volume":"22","author":"Arora","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2022.104232_bib0028","article-title":"Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, & BA.5","author":"Wang","year":"2022","journal-title":"Nature"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:18:34Z","timestamp":1762456714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422004145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":28,"alternative-id":["S2352396422004145"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104232","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104232"}}